Clinical Trial Update: Determination of the Nature of the Endogenous Ligand of TREM-1 and Its Use as a New Diagnostic Biomarker in Sepsis

View source ↗

Summary

The clinical trial evaluating the endogenous ligand of TREM-1 as a diagnostic biomarker for sepsis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sepsis

Snippet

Sponsor: Centre Hospitalier Universitaire Dijon | Conditions: Sepsis | Status: WITHDRAWN